Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ImmuCell Corp ICCC

Healthcare Biotechnology
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which... see more

Recent & Breaking News (NDAQ:ICCC)

ImmuCell Announces Financial Results for 2014

Marketwired February 11, 2015

ImmuCell to Announce 2014 Full Year and Fourth Quarter Financial Results

Marketwired February 4, 2015

ImmuCell to Present at LD Micro Conference on December 2, 2014

Marketwired November 25, 2014

ImmuCell Announces Financial Results for Third Quarter of 2014

Marketwired November 12, 2014

ImmuCell to Announce Third Quarter Fiscal Year 2014 Financial Results

Marketwired November 3, 2014

ImmuCell Participating at Multiple Dairy and Beef Industry Events Throughout September 2014

Marketwired September 17, 2014

ImmuCell Announces Financial Results for the Second Quarter of 2014

Marketwired August 12, 2014

ImmuCell Initiates Pivotal Effectiveness Study to Prevent Calf Scours Caused by Rotavirus

Marketwired July 15, 2014

ImmuCell Commences Manufacture of Nisin Necessary for Approval of Mast Out(R)

Marketwired July 9, 2014

ImmuCell Announces Results for the First Quarter of 2014

Marketwired May 13, 2014

ImmuCell Retains Lytham Partners to Conduct National Investor Relations Program

Marketwired April 10, 2014

ImmuCell Retains Lytham Partners to Conduct National Investor Relations Program

Marketwired April 10, 2014

Paul R. Wainman Joins Board of Directors of ImmuCell Corporation

Marketwired March 20, 2014

ImmuCell Announces Increase in Product Sales and Other Annual Financial Results

Marketwired February 13, 2014

ImmuCell Announces Increased Product Sales and Continued Profitability

Marketwired November 12, 2013

ImmuCell Announces Increase in Product Sales and Continued Profitability

Marketwired August 12, 2013

ImmuCell Suspends Mast Out(R) Partnering Effort; Pursuit of FDA Product Approval to Continue

Marketwired July 18, 2013

First Defense(R) Is Now OMRI Listed and May Be Used With Certified Organic Dairy and Beef Cattle

Marketwired July 11, 2013

ImmuCell Announces Increase in Product Sales and Continued Profitability

Marketwired May 14, 2013

ImmuCell Announces Product Sales Increases and Other Financial Results

Marketwired February 14, 2013